N
Research Areas
Biography and Research Information
OverviewAI-generated summary
Nickolas Gustavison's research focuses on cancer treatment and pharmacology, with a specific interest in targeted drug delivery. His recent publication investigates the delivery of rapamycin via epidermal growth factor receptors in pancreatic cancer cells, demonstrating its potential to inhibit cell proliferation and induce apoptosis. This work aligns with broader interests in cancer-related molecular mechanisms and disease mechanisms research. Gustavison has collaborated with researchers from the University of Arkansas at Fayetteville and the University of Arkansas at Little Rock, contributing to a shared publication record. His current scholarly output includes two publications and one citation, with an h-index of 1.
Metrics
- h-index: 1
- Publications: 2
- Citations: 1
Selected Publications
-
Investigating the impact of multinational collaborations on cultural understanding, health disparities, biomedical innovations, and professional development through project-based learning (2026)
-
Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025)
Collaboration Network
Top Collaborators
Adeolu Sunday Oluremi
University of Arkansas at Little Rock (US)
1 shared publication
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Christofer Baldwin
University of Arkansas at Fayetteville
1 shared publication
In database
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Mujeebat Bashiru
University of Arkansas at Little Rock
1 shared publication
In database
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Adeniyi Oyebade
University of Arkansas at Little Rock
1 shared publication
In database
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Noureen Siraj
University of Arkansas at Little Rock
1 shared publication
In database
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Raj R. Rao
University of Arkansas at Fayetteville
1 shared publication
In database
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Nawab Ali
University of Arkansas at Little Rock
1 shared publication
In database
- Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis
Similar Researchers
Based on overlapping research topics
Zachary McConnell
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Pancreatic and Hepatic Oncology Research
Nanoparticle-Based Drug Delivery
Monica Graziutti
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Disease Mechanisms Research
Mattie R Nester
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Disease Mechanisms Research
Marius B. Nagalo
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Pancreatic and Hepatic Oncology Research
Nanoparticle-Based Drug Delivery
Noemi Garcia Garcia
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Receptor Mechanisms and Signaling
Disease Mechanisms Research
Christopher Salmon
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Pancreatic and Hepatic Oncology Research
Nanoparticle-Based Drug Delivery